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kien@uAbstract Aim: The present study explored (a) the discharge of breast cancer patients to pri-
mary care by specialists, at the end of hospital follow-up and (b) the experiences and views of
general practitioners (GPs) regarding transfer of follow-up to the primary care setting.
Methods: A cross-sectional survey was performed by sending a self-administered question-
naire to 960 GPs working in the three northern provinces of the Netherlands. Data were ana-
lysed using descriptive statistics.
Results: Of 949 eligible questionnaires, 502 were returned, providing an adjusted response rate
of 53%. In the year before the survey took place, one or more patients aged >60 years, and
5 years after breast-conserving therapy, were discharged to 22% of GPs (n = 112) for fol-
low-up. According to 56% of these GPs, transfer of follow-up was communicated by the hos-
pital. The initiative to arrange follow-up visits and mammography appointments was mainly
taken by patients. In this survey, 40% of GPs (n = 200) were willing to accept exclusive respon-
sibility for follow-up earlier than 5 years after completion of active treatment. Perceived bar-
riers in current and future primary care-based follow-up included: communication with breast
cancer specialists, patients’ preference for specialist follow-up, GPs’ oncology knowledge and
skills and the organisation of follow-up in general practice.
Conclusions: Primary care-based follow-up might be improved if breast cancer specialists dis-
charge patients more actively to their GPs. Survivorship care plans are needed to facilitate
communication across the primary/secondary interface and with patients. Training of GPs
and developing administrative tools may be helpful in arranging follow-up care and using
guidelines in general practice.
 2013 Elsevier Ltd. All rights reserved.lsevier Ltd. All rights reserved.
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After primary treatment for breast cancer, follow-up
examinations in the hospital are common practice. The
aims of follow-up are to detect recurrences at an early
stage, to evaluate and monitor side-eﬀects of treatments
and to provide physical and psychosocial rehabilita-
tion.1,2 Several guidelines exist for follow-up.3–5 In the
Netherlands, the current breast cancer guidelines recom-
mend hospital follow-up for 5 years, including yearly
mammography. After these 5 years, patients aged
>60 years, and treated with breast-conserving therapy,
are discharged to their general practitioner (GP) for
yearly physical examination and two-yearly mammogra-
phy. Specialists have to provide clear instructions on fol-
low-up and how to act in case of complications.6–8
Previous studies have shown that breast cancer spe-
cialists follow patients longer than the guidelines pre-
scribe, due to factors such as younger age, higher
breast cancer stage, family history, treatment-related
morbidity and on-going hormone therapy,3,9 indicating
that specialists have diﬃculty discharging patients to
primary care.9 This diﬃculty may be also explained by
patients’ preference for hospital follow-up and concerns
among patients10–12 and specialists3,13,14 about the level
of oncology knowledge and skills of primary care physi-
cians. It is unknown if Dutch breast cancer patients aged
>60, and treated with breast-conserving therapy, are
actually discharged to their GP after 5 years of hospital
follow-up. Furthermore, little is known about the imple-
mentation of breast cancer follow-up in general practice
and whether this is accepted by Dutch GPs. Two studies
have shown that 51% and 93% of Canadian primary
care physicians were willing to accept exclusive breast
cancer follow-up care immediately or 1–2 years after
treatment completion.15,16 No such studies have been
performed in countries in Europe. Therefore, the present
study explored (a) the discharge of breast cancer
patients to primary care by specialists, at the end of hos-
pital follow-up and (b) the experiences and views of GPs
regarding transfer of follow-up to the primary care
setting.2. Materials and methods
2.1. Setting
A cross-sectional survey was performed in the context
of the Dutch healthcare system, in which primary care
has been at the centre for a long time. Almost all citizens
are registered with a GP, who deals with 95% of health
problems presented by patients.17 Dutch GPs receive a
substantial capitation payment for all registered
patients.17,18
In the Netherlands, the current breast cancer guide-
lines recommend hospital follow-up for 5 years, includ-ing yearly mammography. After these 5 years, patients
aged 660 years have yearly follow-up visits and mam-
mography appointments in the hospital. Patients aged
>60 years who have undergone mastectomy are referred
to the National Screening Programme for two-yearly
mammography. Patients aged >60 years, and treated
with breast-conserving therapy, are discharged to their
general practitioner (GP) for yearly physical examina-
tion and two-yearly mammography.6–82.2. Questionnaire development
A self-administered questionnaire was sent to GPs
working in the three northern provinces of the Nether-
lands (Drenthe, Friesland and Groningen). To develop
the questionnaire, relevant articles concerning primary
care physicians’ views on their role in cancer follow-up
care were reviewed.13,15,16,19,20 Some questions in these
articles were used for the present study and additional
questions were developed. To improve face validity
and content validity, the questionnaire and the cover let-
ter were discussed with 10 GPs from diﬀerent practices.
The ﬁnal questionnaire included personal and profes-
sional characteristics (Table 1), 10 items about current
practice regarding primary care-based follow-up, ﬁve
items about GPs’ willingness to accept exclusive respon-
sibility for follow-up and one item for additional com-
ments and suggestions (Appendix). The ﬁnal version of
the questionnaire took ±10 min to complete.2.3. Sample size calculation
The outcome used to calculate the sample size for this
study was GPs’ willingness to accept exclusive responsi-
bility for follow-up earlier than 5 years after completion
of active treatment. With a proportion of 0.5 (maximum
variance) and a 95% conﬁdence interval (CI), 385 GPs
had to respond to the survey. Assuming a response rate
of 40–50%, based on a previous study among Dutch
GPs,21 769–961 questionnaires had to be sent.2.4. Survey administration
Addresses from 960 GPs in the three northern prov-
inces of the Netherlands were available, and all GPs
were sent the questionnaire according to a modiﬁed ver-
sion of the Dillman Total Design Survey Method.22
Three mailing waves were done. The ﬁrst mailing in Sep-
tember 2010 included a cover letter, the questionnaire
and a post-paid return envelope (initial survey pack).
GPs were asked to respond by post or fax. After 1 week,
non-respondents were sent a reminder card. The remain-
ing non-respondents received a reminder survey pack
3 weeks after the ﬁrst mailing. The questionnaires were
numbered so that non-respondents could be identiﬁed;
Table 1
Personal and practice characteristics of respondents (n = 502) and of all general practitioners (GPs) in the Netherlands.
Survey (total)a Surveyb National 2010c p-Valued
n (%) n (%) n (%)
Sex
Male 332 (66.3) 318 (66.7) 5389 (60.4) 0.006
Female 169 (33.7) 159 (33.3) 3532 (39.6)
Age in years
<45 147 (29.5) 135 (28.4) 3219 (36.1) 0.003
45–54 192 (38.5) 187 (39.3) 3105 (34.8)
>54 160 (32.1) 154 (32.4) 2597 (29.1)





Single-handed 159 (34.7) 152 (34.5) 1605 (18.0) <0.001
Twin 133 (29.0) 132 (30.0) 2515 (28.2)
Group/health centre 166 (36.2) 156 (35.5) 4801 (53.8)
Region
Drenthe 149 (29.7) 139 (29.1) 272 (29.2) 0.996
Friesland 189 (37.7) 184 (38.6) 360 (38.7)
Groningen 163 (32.5) 154 (32.3) 298 (32.0)
a Numbers do not add up to 502 due to missing data.
b Not including free-lance GPs (n = 17) and employment unknown (n = 7).
c Not including free-lance GPs.
d Chi-square test.
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bers were not used in the data analysis.2.5. Statistical analysis
Descriptive statistics were used to summarise the
items of the questionnaire. Personal and practice charac-
teristics of respondents were compared with those of the
entire GP population in the Netherlands.23 Diﬀerences
in characteristics were analysed with the Chi-square test.
Logistic regression analysis was used to evaluate
whether characteristics and current involvement in
breast cancer follow-up were associated with GPs’ will-
ingness to accept exclusive responsibility for follow-up
within 5 years after completion of active treatment.
For all analyses, a p-value of <0.05 was considered to
be statistically signiﬁcant.3. Results
3.1. Personal and practice characteristics
Of the 960 mailed questionnaires, 11 were undeliver-
able due to: an incorrect address (n = 5), retirement (5)
and death (1). Of the remaining 949 questionnaires,
502 were returned, providing an adjusted response rate
of 53%. The majority of GPs were male (66%), older
than 44 years (71%) and in practice for P10 years
(74%) (Table 1). They were almost equally dividedbetween single-handed practices, twin practices and
group practices/health centres. Compared to the entire
GP population in the Netherlands, GPs in the survey
were signiﬁcantly more often male, older and working
in a single-handed practice.3.2. Current practice of primary care-based follow-up
In the year before the survey took place, one or more
patients aged >60 years, and 5 years after breast-con-
serving therapy, were discharged to 22% of GPs
(n = 112) for follow-up (Table 2). Some GPs noted that
breast cancer guidelines are not complied with, and that
patients are almost always followed up by their special-
ist for more than 5 years. According to 56% of GPs
involved in follow-up (n = 59), transfer of this follow-
up was communicated by the hospital. Nevertheless,
several GPs mentioned that they received no clear
instructions from specialists on follow-up and how to
act in case of complications.
During follow-up of the patients most recently seen,
the threemost reported activities carried out byGPswere:
asking the patient about symptoms (74%), performing
clinical breast examination (73%) and requesting a mam-
mogram appointment (63%). In this survey, 31% of GPs
involved in follow-up (n = 33) used the current breast
cancer guideline from theDutch College of General Prac-
titioners. The initiative to arrange follow-up visits and
mammography appointments was mainly taken by
Table 2
Current practice of primary care-based breast cancer follow-up.
n (%)
How many patients were referred back to you in the past year? None 386
(77.5)
One patient 30 (6.0)
Several patients 82 (16.5)
If you have seen several patients for follow-up, please take into consideration only the patient that you have seen most recently:
During the follow-up of this patient, I. . . Asked the patient about symptoms 77 (74.0)
(Multiple answers possible, n = 104) Performed clinical breast examination 76 (73.1)
Requested a mammogram appointment 66 (63.5)
Gave advice 28 (26.9)
Emphasised the importance of breast self-
examination
25 (24.0)
Referred the patient to a specialist 13 (12.5)
Other 11 (10.6)
Did you use the 2008 breast cancer guideline during the follow-up of this patient? No 72 (68.6)
Yes 33 (31.4)
Did the hospital communicate the transfer of the follow-up? No 34 (32.1)
Yes 59 (55.7)
I don’t know 13 (12.3)
Was the transfer of the follow-up clearly communicated by the hospital? (Very) unclear 2 (3.5)
Neutral 9 (15.8)
(Very) clear 46 (80.7)
Who took the initiative to arrange follow-up? (Multiple answers possible, n = 106) The patient herself made an appointment 95 (89.6)




Who keeps in mind that mammography has to be performed every two years?
(Multiple answers possible, n = 106)
Patient herself 94 (88.7)
GP 21 (19.8)
Specialist in the hospital 6 (5.7)
Other 6 (5.7)
Nurse practitioner in general practice 1 (0.9)
Was your role during the follow-up of this patient clear to you? (Very) unclear 21 (19.8)
Neutral 27 (25.5)
(Very) clear 58 (54.7)
How satisﬁed are you with your role in the follow-up of this patient? (Very) dissatisﬁed 6 (5.7)
Neutral 36 (34.0)
(Very) satisﬁed 64 (60.4)
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tioned whether patients or GPs should be responsible
for the organisation of follow-up. Furthermore, several
GPs noted that the electronic medical record system they
used was not suitable for planning follow-up visits. Of
GPs involved in follow-up, 55% (n = 58) experienced
their role during follow-up as (very) clear, and 60%
(n = 64) were (very) satisﬁed with this role.
3.3. GPs’ willingness to accept exclusive responsibility for
follow-up
Of all GPs, 80% (n = 374) stated that their current
contribution to breast cancer follow-up care was ‘just
right’, while 32% (n = 160) believed that ‘they should be
involved at an earlier stage in breast cancer follow-up care’
(Fig. 1). In the survey, 40% of GPs (n = 200) were willing
to accept exclusive responsibility for follow-up earlier
than 5 years after completion of active treatment. In
addition, 19% of GPs (n = 93) were willing to take over
follow-up immediately or 1–2 years after completion of
active treatment. Some GPs commented that they pre-ferred shared follow-up alternately performed by GPs
and specialists. Others stated that earlier transfer of fol-
low-up should depend on patients’ characteristics and
views, and on specialists’ views. Personal and practice
characteristics as well as current involvement in follow-
up were not signiﬁcantly associated with GPs’ willingness
to accept exclusive responsibility for follow-up within
5 years after completion of active treatment (Table 3).
The three main barriers perceived by GPs to take
over follow-up at an earlier stage were: patients’ prefer-
ence for specialist follow-up (65%), own oncology
knowledge and skills (52%) and workload pressure
(36%) (Fig. 2). With respect to their oncology knowl-
edge and skills, 41% of GPs (n = 205) believed that ‘they
had the skills necessary to take over breast cancer follow-
up at an earlier stage’, whereas 20% (n = 97) felt that
‘they had the skills necessary to examine irradiated
breasts to detect local recurrences and second tumours’
(Fig. 1). However, 61% (n = 303) stated that ‘they were
better placed to provide psychosocial support to patients
with breast cancer than specialists’. The three most useful






















Fig. 1. General practitioners’ (GPs’) willingness to accept exclusive responsibility for routine breast cancer follow-up.
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cialists with special focus on follow-up (74%), a refresher
course in breast cancer follow-up (69%) and an updated
breast cancer guideline from the Dutch College of Gen-
eral Practitioners (46%) (Fig. 2). In relation to these bar-
riers and tools, several GPs commented that good
collaboration with specialists, training of GPs in fol-
low-up care and an automated calling system to support
the planning of follow-up visits, would be helpful to take
over follow-up at an earlier stage.3.4. GPs’ recommendations for current and future primary
care-based follow-up
Additional comments/suggestions were given by 50
GPs. Their main recommendations for improving cur-rent and future primary care-based follow-up include
the following: local agreements with specialists on fol-
low-up policy, active discharge of patients by specialists,
adequate supply of written discharge information, quick
referral of patients to the breast cancer clinic when nec-
essary, education and training of GPs in follow-up care
and development of administrative tools to support the
organisation of follow-up in general practice.4. Discussion
In the year before the survey took place, one or more
patients aged >60 years, and 5 years after breast-con-
serving therapy, were discharged to 22% of GPs for fol-
low-up. According to 56% of these GPs, transfer of
follow-up was communicated by the hospital. The
Table 3
Personal and practice characteristics associated with general practitioners’ (GPs’) willingness to accept exclusive responsibility for routine breast
cancer follow-up at an earlier stage. Univariate odds ratios (OR) and 95% conﬁdence intervals (95% CIs) were estimated with logistic regression
analysis.
Willingness
No (n = 295)a Yes (n = 200)
n (%) n (%) OR (CI)
Sex
Male 190 (64.4) 138 (69.0) 1
Female 105 (35.6) 62 (31.0) 0.81 (0.55–1.19)
Age, n (%)
650.0 years 155 (53.1) 90 (45.0) 1
>50.0 years 137 (46.9) 110 (55.0) 1.38 (0.96–1.98)
Practice experience
616.0 years 157 (54.3) 97 (49.5) 1
>16.0 years 132 (45.7) 99 (50.5) 1.21 (0.84–1.75)
Practice setting
Single-handed 98 (36.3) 61 (33.5) 1
Twin 75 (27.8) 56 (30.8) 1.20 (0.75–1.92)
Group/health centre 97 (35.9) 65 (35.7) 1.08 (0.69–1.69)
Region
Drenthe 80 (27.2) 67 (33.5) 1
Friesland 118 (40.1) 67 (33.5) 0.68 (0.44–1.05)
Groningen 96 (32.7) 66 (33.0) 0.82 (0.52–1.29)
Patients referred back to their GP
None 228 (77.3) 155 (77.5) 1
One patient or more 67 (22.7) 45 (22.5) 0.99 (0.64–1.52)
Signiﬁcant at p < 0.05 (*).
a Including ‘responder does not know’.
Fig. 2. Perceived barriers and tools to accept exclusive responsibility
for breast cancer follow-up at an earlier stage.
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appointments was mainly taken by patients. In this sur-
vey, 40% of GPs were willing to accept exclusive respon-
sibility for follow-up earlier than 5 years after
completion of active treatment. Personal and practice
characteristics as well as current involvement in fol-
low-up were not signiﬁcantly associated with GPs’ will-
ingness to accept exclusive responsibility for follow-up.
Perceived barriers in current and future primary care-
based follow-up included: communication with breast
cancer specialists, patients’ preference for specialist fol-
low-up, GPs’ oncology knowledge and skills and the
organisation of follow-up in general practice.
The ﬁnding that patients were discharged for follow-
up to only 22% of GPs in our survey might indicate
possible non-compliance and/or non-familiarity of
specialists with the current guidelines for follow-up. This
is in accordance with previous studies suggesting that
specialists have diﬃculty discharging patients to primary
care.3,9 We also found that only 31% of the GPs used the
current breast cancer guideline from the Dutch College
of General Practitioners during the follow-up of their
patient. Previous studies have shown that clinical guide-
lines in general practice with low compliance rates were
those requiring new knowledge and skills, not easy to
follow, not compatible with existing norms and values
1842 C. Roorda et al. / European Journal of Cancer 49 (2013) 1836–1844and not taking into account patient preferences, abilities
and needs.24–26
In the literature, deﬁciencies in communication
between primary care and specialist care are frequently
mentioned as the major factor aﬀecting the follow-up
of cancer patients.21,27 Only 56% of GPs involved in fol-
low-up reported that transfer of this follow-up was com-
municated by the hospital. Good communication across
the primary/secondary interface is necessary to guaran-
tee that GPs as well as patients get clear instructions on
follow-up and how to act in case of complications.6,7 A
major tool perceived by GPs to take over follow-up at
an earlier stage included a patient-speciﬁc letter from
specialists with special focus on follow-up (74%). Struc-
tured consultation and discharge letters, as well as clin-
ical practice guidelines, are essential elements of
survivorship care plans, which are useful instruments
to facilitate communication among patients and health-
care providers.4,27,28
Willingness of GPs to accept exclusive responsibility
for breast cancer follow-up has not been studied in Eur-
ope. Two surveys showed that 51% and 93% of Cana-
dian primary care physicians were willing to accept
exclusive breast cancer follow-up care immediately or
1–2 years after treatment completion.15,16 In our survey,
only 19% of GPs were willing to take over follow-up
immediately or 1–2 years after completion of active
treatment. However, higher percentages reported in
the previous studies may be related to the fact that many
Canadian primary care physicians already provide
exclusive care to cancer survivors,15,16 showing that a
physician’s self-conﬁdence in this domain improves as
the number of survivors in the practice increases.29 Nev-
ertheless, current involvement in breast cancer follow-up
did not predict the willingness of GPs to take over fol-
low-up in our study. Another explanation for diﬀerences
in willingness between primary care providers in Canada
and the Netherlands might be the relative inﬂuence of
health care ﬁnancing in these countries. Most Canadian
physicians are remunerated on a fee-for-service basis,
while Dutch GPs receive a substantial capitation pay-
ment for all registered patients.17,18
An important barrier perceived by GPs to take over
follow-up at an earlier stage is the patient’s preference
for specialist follow-up. This is in accordance with other
studies30–33 showing that patients tend to prefer the
most familiar situation.31,32 Patients’ preference for spe-
cialist follow-up,25 together with guideline non-adher-
ence among specialists and GPs, may explain the
ﬁnding that patients were discharged for follow-up to
only 22% of GPs in our survey. When follow-up is trans-
ferred to the primary care setting at an earlier stage,
patients need to be well informed about the advantages
and limitations of several follow-up models, so they can
make an informed choice about their individual follow-
up arrangements.4,34Another barrier perceived by GPs to take over fol-
low-up at an earlier stage involves their own level of
oncology knowledge and skills. This belief was sup-
ported by other studies in which patients10–12 and oncol-
ogists,3,13,14 as well as primary care physicians14
expressed concerns about the ability of primary care
physicians to provide adequate breast cancer follow-up
care. A useful tool perceived by GPs to take over fol-
low-up at an earlier stage included a refresher course
in breast cancer follow-up. Training and education of
GPs and other primary care physicians seems essential
to ensure that they have adequate knowledge and feel
conﬁdent to provide follow-up care.14,29 However, their
self-conﬁdence in this domain may also improve as the
number of survivors in their practice increases,29 as a
consequence of providing follow-up at an earlier stage.
The organisation of follow-up in general practice was
considered as a barrier in current and future primary
care-based follow-up. An automated calling system inte-
grated in the current electronic medical record systems
(as well as other administrative tools) might be helpful
to organise the follow-up in general practice. Another
option may be the introduction of oncology nurses in
primary care,3 just as primary care nurses were intro-
duced in Dutch general practice, partly to shift diabetes
care from hospital to primary care.35 Nevertheless, as
the initiative to arrange follow-up visits and mammog-
raphy appointments was mainly taken by patients in
our study, the question arises whether follow-up should
be patient-driven or primary care provider-driven.36
Recently, Blaauwbroek et al.37 developed a (web-based)
survivorship care plan for adult survivors of childhood
cancer and their GPs. This plan was greatly appreciated
by the survivors, who had become more aware of poten-
tial risks of health problems and of the beneﬁts of fol-
low-up.
Our survey explored whether Dutch breast cancer
patients aged >60, and treated with breast-conserving
therapy, are actually discharged to their GP after 5 years
of hospital follow-up. Furthermore, this the ﬁrst study
in Europe to evaluate the implementation of breast can-
cer follow-up in general practice and the acceptance of
this follow-up among GPs. The response rate was com-
parable to that observed in another study among Dutch
GPs.21 GPs in our study were signiﬁcantly more often
male, older and working in a single-handed practice
than all Dutch GPs.23 As we found that these character-
istics were not associated with GPs’ willingness to accept
exclusive responsibility for follow-up, we believe that
our ﬁndings provide important insight into the dis-
charge of breast cancer patients at the end of hospital
follow-up and that these are also relevant to primary
care providers in other countries.
Based on the results of this study, primary care-based
follow-up might be improved if breast cancer specialists
discharge patients more actively to their GPs.
C. Roorda et al. / European Journal of Cancer 49 (2013) 1836–1844 1843Survivorship care plans are needed to facilitate commu-
nication across the primary/secondary interface and
with patients. Training of GPs and developing adminis-
trative tools may be helpful in arranging follow-up care
and using guidelines in general practice.
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